Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Alzheimer's Disease Drug Market 2018, Forecast to 2023

June 2018 | 136 pages | ID: G2DC69DF0BBEN
GlobalInfoResearch

Abstracts

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Scope of the Report:

This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of alzheimer’s disease drug change huge.
The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.
Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.

The worldwide market for Alzheimer's Disease Drug is expected to grow at a CAGR of roughly -11.3% over the next five years, will reach 1580 million US$ in 2023, from 2870 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Allergan
• Eisai
• Novartis
• Daiichi Sankyo
• Merz Pharma
• Pfizer
• Johnson & Johnson
• Lundbeck

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Donepezil
• Memantine
• Rivastigmine

Market Segment by Applications, can be divided into

• Early to Moderate Stages
• Moderate to Severe Stages

There are 15 Chapters to deeply display the global Alzheimer's Disease Drug market.

Chapter 1, to describe Alzheimer's Disease Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer's Disease Drug, with sales, revenue, and price of Alzheimer's Disease Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer's Disease Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer's Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer's Disease Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Alzheimer's Disease Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Donepezil
  1.2.2 Memantine
  1.2.3 Rivastigmine
1.3 Market Analysis by Applications
  1.3.1 Early to Moderate Stages
  1.3.2 Moderate to Severe Stages
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Allergan
  2.1.1 Business Overview
    2.1.1.1 Allergan Description
    2.1.1.2 Allergan Headquarter, Main Business and Finance Overview
  2.1.2 Allergan Alzheimer's Disease Drug Product Introduction
    2.1.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Alzheimer's Disease Drug Product Information
  2.1.3 Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Allergan Alzheimer's Disease Drug Market Share in 2017
2.2 Eisai
  2.2.1 Business Overview
    2.2.1.1 Eisai Description
    2.2.1.2 Eisai Headquarter, Main Business and Finance Overview
  2.2.2 Eisai Alzheimer's Disease Drug Product Introduction
    2.2.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Alzheimer's Disease Drug Product Information
  2.2.3 Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Eisai Alzheimer's Disease Drug Market Share in 2017
2.3 Novartis
  2.3.1 Business Overview
    2.3.1.1 Novartis Description
    2.3.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.3.2 Novartis Alzheimer's Disease Drug Product Introduction
    2.3.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Alzheimer's Disease Drug Product Information
  2.3.3 Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Novartis Alzheimer's Disease Drug Market Share in 2017
2.4 Daiichi Sankyo
  2.4.1 Business Overview
    2.4.1.1 Daiichi Sankyo Description
    2.4.1.2 Daiichi Sankyo Headquarter, Main Business and Finance Overview
  2.4.2 Daiichi Sankyo Alzheimer's Disease Drug Product Introduction
    2.4.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Alzheimer's Disease Drug Product Information
  2.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Daiichi Sankyo Alzheimer's Disease Drug Market Share in 2017
2.5 Merz Pharma
  2.5.1 Business Overview
    2.5.1.1 Merz Pharma Description
    2.5.1.2 Merz Pharma Headquarter, Main Business and Finance Overview
  2.5.2 Merz Pharma Alzheimer's Disease Drug Product Introduction
    2.5.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Alzheimer's Disease Drug Product Information
  2.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Merz Pharma Alzheimer's Disease Drug Market Share in 2017
2.6 Pfizer
  2.6.1 Business Overview
    2.6.1.1 Pfizer Description
    2.6.1.2 Pfizer Headquarter, Main Business and Finance Overview
  2.6.2 Pfizer Alzheimer's Disease Drug Product Introduction
    2.6.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Alzheimer's Disease Drug Product Information
  2.6.3 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Pfizer Alzheimer's Disease Drug Market Share in 2017
2.7 Johnson & Johnson
  2.7.1 Business Overview
    2.7.1.1 Johnson & Johnson Description
    2.7.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
  2.7.2 Johnson & Johnson Alzheimer's Disease Drug Product Introduction
    2.7.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Alzheimer's Disease Drug Product Information
  2.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Johnson & Johnson Alzheimer's Disease Drug Market Share in 2017
2.8 Lundbeck
  2.8.1 Business Overview
    2.8.1.1 Lundbeck Description
    2.8.1.2 Lundbeck Headquarter, Main Business and Finance Overview
  2.8.2 Lundbeck Alzheimer's Disease Drug Product Introduction
    2.8.2.1 Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Alzheimer's Disease Drug Product Information
  2.8.3 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Lundbeck Alzheimer's Disease Drug Market Share in 2017

3 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 Global Alzheimer's Disease Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer's Disease Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Alzheimer's Disease Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Alzheimer's Disease Drug Manufacturer Market Share in 2017
  3.4.2 Top 5 Alzheimer's Disease Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET ANALYSIS BY REGIONS

4.1 Global Alzheimer's Disease Drug Sales, Revenue and Market Share by Regions
  4.1.1 Global Alzheimer's Disease Drug Sales by Regions (2013-2018)
  4.1.2 Global Alzheimer's Disease Drug Revenue by Regions (2013-2018)
4.2 North America Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ALZHEIMER'S DISEASE DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Alzheimer's Disease Drug Sales, Revenue and Market Share by Countries
  5.1.1 North America Alzheimer's Disease Drug Sales by Countries (2013-2018)
  5.1.2 North America Alzheimer's Disease Drug Revenue by Countries (2013-2018)
  5.1.3 United States Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  5.1.4 Canada Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
5.2 North America Alzheimer's Disease Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Alzheimer's Disease Drug Sales by Manufacturers (2016-2017)
  5.2.2 North America Alzheimer's Disease Drug Revenue by Manufacturers (2016-2017)
5.3 North America Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Alzheimer's Disease Drug Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Alzheimer's Disease Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Alzheimer's Disease Drug Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Alzheimer's Disease Drug Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Alzheimer's Disease Drug Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ALZHEIMER'S DISEASE DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Alzheimer's Disease Drug Sales, Revenue and Market Share by Countries
  6.1.1 Europe Alzheimer's Disease Drug Sales by Countries (2013-2018)
  6.1.2 Europe Alzheimer's Disease Drug Revenue by Countries (2013-2018)
  6.1.3 Germany Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  6.1.4 UK Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  6.1.5 France Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  6.1.6 Russia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  6.1.7 Italy Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
6.2 Europe Alzheimer's Disease Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Alzheimer's Disease Drug Sales by Manufacturers (2016-2017)
  6.2.2 Europe Alzheimer's Disease Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Alzheimer's Disease Drug Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Alzheimer's Disease Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Alzheimer's Disease Drug Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Alzheimer's Disease Drug Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Alzheimer's Disease Drug Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ALZHEIMER'S DISEASE DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Alzheimer's Disease Drug Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Alzheimer's Disease Drug Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Alzheimer's Disease Drug Revenue by Countries (2013-2018)
  7.1.3 China Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  7.1.4 Japan Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  7.1.5 Korea Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  7.1.6 India Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Alzheimer's Disease Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Alzheimer's Disease Drug Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Alzheimer's Disease Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Alzheimer's Disease Drug Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Alzheimer's Disease Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Alzheimer's Disease Drug Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Alzheimer's Disease Drug Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Alzheimer's Disease Drug Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ALZHEIMER'S DISEASE DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Alzheimer's Disease Drug Sales, Revenue and Market Share by Countries
  8.1.1 South America Alzheimer's Disease Drug Sales by Countries (2013-2018)
  8.1.2 South America Alzheimer's Disease Drug Revenue by Countries (2013-2018)
  8.1.3 Brazil Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
8.2 South America Alzheimer's Disease Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Alzheimer's Disease Drug Sales by Manufacturers (2016-2017)
  8.2.2 South America Alzheimer's Disease Drug Revenue by Manufacturers (2016-2017)
8.3 South America Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Alzheimer's Disease Drug Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Alzheimer's Disease Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Alzheimer's Disease Drug Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Alzheimer's Disease Drug Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Alzheimer's Disease Drug Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Alzheimer's Disease Drug Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Alzheimer's Disease Drug Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  9.1.4 UAE Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Alzheimer's Disease Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Alzheimer's Disease Drug Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Alzheimer's Disease Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Alzheimer's Disease Drug Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Alzheimer's Disease Drug Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Alzheimer's Disease Drug Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET SEGMENT BY TYPE

10.1 Global Alzheimer's Disease Drug Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Alzheimer's Disease Drug Sales and Market Share by Type (2013-2018)
  10.1.2 Global Alzheimer's Disease Drug Revenue and Market Share by Type (2013-2018)
10.2 Donepezil Sales Growth and Price
  10.2.1 Global Donepezil Sales Growth (2013-2018)
  10.2.2 Global Donepezil Price (2013-2018)
10.3 Memantine Sales Growth and Price
  10.3.1 Global Memantine Sales Growth (2013-2018)
  10.3.2 Global Memantine Price (2013-2018)
10.4 Rivastigmine Sales Growth and Price
  10.4.1 Global Rivastigmine Sales Growth (2013-2018)
  10.4.2 Global Rivastigmine Price (2013-2018)

11 GLOBAL ALZHEIMER'S DISEASE DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Alzheimer's Disease Drug Sales Market Share by Application (2013-2018)
11.2 Early to Moderate Stages Sales Growth (2013-2018)
11.3 Moderate to Severe Stages Sales Growth (2013-2018)

12 ALZHEIMER'S DISEASE DRUG MARKET FORECAST (2018-2023)

12.1 Global Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer's Disease Drug Market Forecast by Regions (2018-2023)
  12.2.1 North America Alzheimer's Disease Drug Market Forecast (2018-2023)
  12.2.2 Europe Alzheimer's Disease Drug Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Alzheimer's Disease Drug Market Forecast (2018-2023)
  12.2.4 South America Alzheimer's Disease Drug Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Alzheimer's Disease Drug Market Forecast (2018-2023)
12.3 Alzheimer's Disease Drug Market Forecast by Type (2018-2023)
  12.3.1 Global Alzheimer's Disease Drug Sales Forecast by Type (2018-2023)
  12.3.2 Global Alzheimer's Disease Drug Market Share Forecast by Type (2018-2023)
12.4 Alzheimer's Disease Drug Market Forecast by Application (2018-2023)
  12.4.1 Global Alzheimer's Disease Drug Sales Forecast by Application (2018-2023)
  12.4.2 Global Alzheimer's Disease Drug Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Alzheimer's Disease Drug Picture
Table Product Specifications of Alzheimer's Disease Drug
Figure Global Alzheimer's Disease Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Alzheimer's Disease Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Alzheimer's Disease Drug by Types in 2017
Figure Donepezil Picture
Table Major Manufacturers of Donepezil
Figure Memantine Picture
Table Major Manufacturers of Memantine
Figure Rivastigmine Picture
Table Major Manufacturers of Rivastigmine
Figure Alzheimer's Disease Drug Sales Market Share by Applications in 2017
Figure Early to Moderate Stages Picture
Figure Moderate to Severe Stages Picture
Figure United States Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2013-2023)
Table Allergan Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Allergan Alzheimer's Disease Drug Product
Table Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Allergan Alzheimer's Disease Drug Revenue Market Share in 2017
Table Eisai Headquarter, Established, Main Business and Finance Overview (2017)
Table Eisai Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Eisai Alzheimer's Disease Drug Product
Table Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eisai Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Eisai Alzheimer's Disease Drug Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Alzheimer's Disease Drug Product
Table Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Novartis Alzheimer's Disease Drug Revenue Market Share in 2017
Table Daiichi Sankyo Headquarter, Established, Main Business and Finance Overview (2017)
Table Daiichi Sankyo Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Daiichi Sankyo Alzheimer's Disease Drug Product
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daiichi Sankyo Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Daiichi Sankyo Alzheimer's Disease Drug Revenue Market Share in 2017
Table Merz Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Merz Pharma Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Merz Pharma Alzheimer's Disease Drug Product
Table Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merz Pharma Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Merz Pharma Alzheimer's Disease Drug Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Pfizer Alzheimer's Disease Drug Product
Table Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Pfizer Alzheimer's Disease Drug Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Alzheimer's Disease Drug Product
Table Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Johnson & Johnson Alzheimer's Disease Drug Revenue Market Share in 2017
Table Lundbeck Headquarter, Established, Main Business and Finance Overview (2017)
Table Lundbeck Alzheimer's Disease Drug Production Bases, Sales Regions and Major Competitors
Table Lundbeck Alzheimer's Disease Drug Product
Table Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lundbeck Alzheimer's Disease Drug Sales Market Share in 2017
Figure Global Lundbeck Alzheimer's Disease Drug Revenue Market Share in 2017
Table Global Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure Global Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure Global Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table Global Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure Global Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Global Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table Global Alzheimer's Disease Drug Price by Manufacturer (2016-2017)
Figure Top 3 Alzheimer's Disease Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Alzheimer's Disease Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Global Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table Global Alzheimer's Disease Drug Sales by Regions (2013-2018)
Table Global Alzheimer's Disease Drug Sales Market Share by Regions (2013-2018)
Table Global Alzheimer's Disease Drug Revenue by Regions (2013-2018)
Figure Global Alzheimer's Disease Drug Revenue Market Share by Regions in 2013
Figure Global Alzheimer's Disease Drug Revenue Market Share by Regions in 2017
Figure North America Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure North America Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Figure South America Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure South America Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Figure North America Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table North America Alzheimer's Disease Drug Sales by Countries (2013-2018)
Table North America Alzheimer's Disease Drug Sales Market Share by Countries (2013-2018)
Figure North America Alzheimer's Disease Drug Sales Market Share by Countries in 2013
Figure North America Alzheimer's Disease Drug Sales Market Share by Countries in 2017
Table North America Alzheimer's Disease Drug Revenue by Countries (2013-2018)
Table North America Alzheimer's Disease Drug Revenue Market Share by Countries (2013-2018)
Figure North America Alzheimer's Disease Drug Revenue Market Share by Countries in 2013
Figure North America Alzheimer's Disease Drug Revenue Market Share by Countries in 2017
Figure United States Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Canada Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Mexico Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Table North America Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure North America Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure North America Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table North America Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure North America Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure North America Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table North America Alzheimer's Disease Drug Sales by Type (2013-2018)
Table North America Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table North America Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table North America Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Table North America Alzheimer's Disease Drug Sales by Application (2013-2018)
Table North America Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Table North America Alzheimer's Disease Drug Revenue by Application (2013-2018)
Table North America Alzheimer's Disease Drug Revenue Share by Application (2013-2018)
Figure Europe Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table Europe Alzheimer's Disease Drug Sales by Countries (2013-2018)
Table Europe Alzheimer's Disease Drug Sales Market Share by Countries (2013-2018)
Table Europe Alzheimer's Disease Drug Revenue by Countries (2013-2018)
Figure Europe Alzheimer's Disease Drug Revenue Market Share by Countries in 2016
Figure Europe Alzheimer's Disease Drug Revenue Market Share by Countries in 2017
Figure Germany Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure UK Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure France Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Russia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Italy Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Table Europe Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure Europe Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure Europe Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table Europe Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure Europe Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table Europe Alzheimer's Disease Drug Sales by Type (2013-2018)
Table Europe Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table Europe Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table Europe Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Table Europe Alzheimer's Disease Drug Sales by Application (2013-2018)
Table Europe Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Table Europe Alzheimer's Disease Drug Revenue by Application (2013-2018)
Table Europe Alzheimer's Disease Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales by Countries (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Countries 2017
Table Asia-Pacific Alzheimer's Disease Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Countries 2017
Figure China Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Japan Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Korea Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure India Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Alzheimer's Disease Drug Sales by Type (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales by Application (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Revenue by Application (2013-2018)
Table Asia-Pacific Alzheimer's Disease Drug Revenue Share by Application (2013-2018)
Figure South America Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table South America Alzheimer's Disease Drug Sales by Countries (2013-2018)
Table South America Alzheimer's Disease Drug Sales Market Share by Countries (2013-2018)
Figure South America Alzheimer's Disease Drug Sales Market Share by Countries in 2017
Table South America Alzheimer's Disease Drug Revenue by Countries (2013-2018)
Table South America Alzheimer's Disease Drug Revenue Market Share by Countries (2013-2018)
Figure South America Alzheimer's Disease Drug Revenue Market Share by Countries in 2017
Figure Brazil Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Argentina Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Colombia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Table South America Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure South America Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure South America Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table South America Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure South America Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure South America Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table South America Alzheimer's Disease Drug Sales by Type (2013-2018)
Table South America Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table South America Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table South America Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Table South America Alzheimer's Disease Drug Sales by Application (2013-2018)
Table South America Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Table South America Alzheimer's Disease Drug Revenue by Application (2013-2018)
Table South America Alzheimer's Disease Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Alzheimer's Disease Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales by Countries (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Alzheimer's Disease Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure UAE Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Egypt Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Figure South Africa Alzheimer's Disease Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Alzheimer's Disease Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Alzheimer's Disease Drug Sales by Type (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales by Application (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2013-2018)
Table Middle East and Africa Alzheimer's Disease Drug Revenue Share by Application (2013-2018)
Table Global Alzheimer's Disease Drug Sales by Type (2013-2018)
Table Global Alzheimer's Disease Drug Sales Share by Type (2013-2018)
Table Global Alzheimer's Disease Drug Revenue by Type (2013-2018)
Table Global Alzheimer's Disease Drug Revenue Share by Type (2013-2018)
Figure Global Donepezil Sales Growth (2013-2018)
Figure Global Donepezil Price (2013-2018)
Figure Global Memantine Sales Growth (2013-2018)
Figure Global Memantine Price (2013-2018)
Figure Global Rivastigmine Sales Growth (2013-2018)
Figure Global Rivastigmine Price (2013-2018)
Table Global Alzheimer's Disease Drug Sales by Application (2013-2018)
Table Global Alzheimer's Disease Drug Sales Share by Application (2013-2018)
Figure Global Early to Moderate Stages Sales Growth (2013-2018)
Figure Global Moderate to Severe Stages Sales Growth (2013-2018)
Figure Global Alzheimer's Disease Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Alzheimer's Disease Drug Sales Forecast by Regions (2018-2023)
Table Global Alzheimer's Disease Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Alzheimer's Disease Drug Market Forecast (2018-2023)
Figure Europe Sales Alzheimer's Disease Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Alzheimer's Disease Drug Market Forecast (2018-2023)
Figure South America Sales Alzheimer's Disease Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Alzheimer's Disease Drug Market Forecast (2018-2023)
Table Global Alzheimer's Disease Drug Sales Forecast by Type (2018-2023)
Table Global Alzheimer's Disease Drug Market Share Forecast by Type (2018-2023)
Table Global Alzheimer's Disease Drug Sales Forecast by Application (2018-2023)
Table Global Alzheimer's Disease Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List